Technical Analysis for ZYME - Zymeworks Inc.

Grade Last Price % Change Price Change
grade A 35.98 2.24% 0.79
ZYME closed up 2.24 percent on Thursday, November 14, 2019, on 62 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Up Up
See historical ZYME trend table...

Date Alert Name Type % Chg
MACD Bullish Signal Line Cross Bullish 0.00%
MACD Bearish Signal Line Cross Bearish 2.24%
Outside Day Range Expansion 2.24%
Up 3 Days in a Row Strength 1.78%
1,2,3 Pullback Bullish Bullish Swing Setup 5.08%
180 Bullish Setup Bullish Swing Setup 5.08%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 5.08%
Wide Bands Range Expansion 5.08%
Inside Day Range Contraction 8.37%
Wide Bands Range Expansion 8.37%

Older signals for ZYME ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Zymeworks Inc is a Canada-based clinical-stage biopharmaceutical company. The Company focuses on the discovery, development and commercialization of multifunctional biotherapeutics. The Company's ZymeCAD platform is for protein modeling and structure-guided protein engineering. The Company's platforms include Azymetric Platform, AlbuCORE Platform, EFECT Platform and Zymelink Conjugation Platform + Cytotoxins. The Company's lead product candidate, ZW25, is a bispecific antibody, which is being evaluated in an adaptive Phase I clinical trial. Its ZW33 is a bi-specific antibody that delivers a cytotoxic payload to cancers cells by binding to different epitopes (bi-paratopic targeting) of the overexpressed HER2 protein. It focuses on developing a pipeline of preclinical product candidates and discovery-stage programs in immuno-oncology and other therapeutic areas. It analyzes protein characteristics to develop the scope of protein engineering to tackle biological systems.
Medicine Biopharmaceutical Medical Specialties Immunology Cancers Immune System Monoclonal Antibodies Cancer Immunotherapy Antibody Sutro Biopharma Glycoproteins Protein Engineering Biological Systems
Is ZYME a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 36.89
52 Week Low 10.72
Average Volume 297,914
200-Day Moving Average 21.9588
50-Day Moving Average 29.2952
20-Day Moving Average 33.244
10-Day Moving Average 35.013
Average True Range 1.5355
ADX 34.64
+DI 27.7609
-DI 13.1183
Chandelier Exit (Long, 3 ATRs ) 32.2835
Chandelier Exit (Short, 3 ATRs ) 32.5265
Upper Bollinger Band 37.478
Lower Bollinger Band 29.01
Percent B (%b) 0.82
BandWidth 25.472266
MACD Line 1.9115
MACD Signal Line 1.9071
MACD Histogram 0.0044
Fundamentals Value
Market Cap 911.71 Million
Num Shares 25.3 Million
EPS -3.52
Price-to-Earnings (P/E) Ratio -10.22
Price-to-Sales 35.32
Price-to-Book 2.18
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 38.20
Resistance 3 (R3) 38.10 37.26 37.83
Resistance 2 (R2) 37.26 36.69 37.31 37.71
Resistance 1 (R1) 36.62 36.35 36.94 36.72 37.58
Pivot Point 35.78 35.78 35.94 35.83 35.78
Support 1 (S1) 35.14 35.21 35.46 35.24 34.38
Support 2 (S2) 34.30 34.87 34.35 34.25
Support 3 (S3) 33.66 34.30 34.13
Support 4 (S4) 33.76